11/11/2022 EMVision Backed By NSW Medical Devices Fund With $2.5m Grant
More non-dilutive funding, an area in which EMV has been highly focused & consistent. Outside validation of the Tech and recognition of the need for the products.
13/11/2022 Portable Brain Scanner Delivered to First Clinical Site
Quote: EMVision CEO, Dr Ron Weinberger commented: “This is a pivotal moment for our company. This multisite trial across pre-validation and subsequent validation phases will provide crucial clinical evidence for the safety and efficacy of our product.
____________________________________________
PS: would suggest anyone researching EMV not forget to look into the potential recurring revenues of consumables, should the tech reach commercialization...
